%0期刊文章%@ 2369-2960 %I JMIR出版物%V 7% 卡塔尔世界杯8强波胆分析N 5% P e22160% T 2000年和2017年东地中海地区宫颈癌负担:全球疾病负担研究%A Safaeian,Fereshteh %A Ghaemimood,Shidrokh %A El-Khatib,Ziad %A Enayati,Sahba %A Mirkazemi,Roksana %A Reeder,Bruce %+公共卫生研究生研究，Bahá'í高等教育学院，伊朗德黑兰，98 9388520250，shidrokh.ghaemi@gmail.com %K宫颈癌%K东地中海区域%K疾病负担%K癌症%K负担%K不平等%K死亡率%K可预防疾病%D 2021 %7 12.5.2021 %9原始论文%J JMIR公共卫生监测%G英文%X背景:宫颈癌是一个日益严重的健康问题，特别是在资源有限的环境中。目的:本研究的目的是通过使用汇总数据分析方法，评估2000年至2017年期间东地中海区域(EMR)和全球宫颈癌死亡率和残疾调整生命年(DALYs)的负担。方法:我们在国家一级采用生态方法。这包括从公开的数据库中提取数据，并通过以下3个步骤将它们链接在一起:(1)提取2000年和2017年全球疾病负担(GBD)研究的数据，(2)根据世界银行人均国内生产总值对EMR国家进行分类，(3)将联合国人口统计司(20-29岁、30-49岁和50岁)和GBD的数据与人均国民总收入和全球提取的数据联系起来，包括每个国家的宫颈癌死亡率和DALY数字和比率。宫颈癌死亡率由GBD研究使用以下公式提供:宫颈癌死亡人数× 10万/相应年龄组的女性人口。结果:在EMR中，宫颈癌死亡的绝对人数从2000年(n=6326)增加到2017年(n=8537); however, the mortality rate due to this disease decreased from the year 2000 (2.7 per 100,000) to the year 2017 (2.5 per 100,000). According to age-specific data, the age group ≥50 years showed the highest mortality rate in both EMR countries and globally, and the age group of 20-29 years showed the lowest mortality rate both globally and in the EMR countries. Further, the rates of cervical cancer DALYs in the EMR were lower compared to the global rates (2.7 vs 6.8 in 2000 and 2.5 vs 6.8 in 2017 for mortality rate per 100,000; 95.8 vs 222.2 in 2000 and 86.3 vs 211.8 in 2017 for DALY rate per 100,000; respectively). However, the relative difference in the number of DALYs due to cervical cancer between the year 2000 and year 2017 in the EMR was higher than that reported globally (34.9 vs 24.0 for the number of deaths and 23.5 vs 18.1 for the number of DALYs, respectively). Conclusions: We found an increase in the burden of cervical cancer in the EMR as per the data on the absolute number of deaths and DALYs. Further, we found that the health care system has an increased number of cases to deal with, despite the decrease in the absolute number of deaths and DALYs. Cervical cancer is preventable if human papilloma vaccination is taken and early screening is performed. Therefore, we recommend identifying effective vaccination programs and interventions to reduce the burden of this disease. %M 33978592 %R 10.2196/22160 %U https://publichealth.www.mybigtv.com/2021/5/e22160 %U https://doi.org/10.2196/22160 %U http://www.ncbi.nlm.nih.gov/pubmed/33978592